Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEPSteps for PrEP Adherence in Substance Users
NCT03512418Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jun 2019
- Primary completion
- Apr 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Brigham and Women's Hospital. Primary endpoint: Feasibility of the Adherence Intervention Qualitative and Quantitive Questionnaire at 3 months. Started Jun 2019; status: completed.
Beyond the preview
Go deeper on NCT03512418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03512418.